{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:52:47Z","timestamp":1780455167056,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"47","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.vaccine.2012.08.063","type":"journal-article","created":{"date-parts":[[2012,9,7]],"date-time":"2012-09-07T12:15:27Z","timestamp":1347020127000},"page":"6656-6664","source":"Crossref","is-referenced-by-count":55,"title":["Phase II, dose ranging study of the safety and immunogenicity of single dose West Nile vaccine in healthy adults \u226550 years of age"],"prefix":"10.1016","volume":"30","author":[{"given":"Gustavo H.","family":"Dayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aileen","family":"Buldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Risi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2012.08.063_bib0005","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.4065\/78.9.1137","article-title":"West Nile virus: epidemiology, clinical presentation, diagnosis, and prevention","volume":"78","author":"Sampathkumar","year":"2003","journal-title":"Mayo Clin Proc"},{"issue":"10","key":"10.1016\/j.vaccine.2012.08.063_bib0010","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1086\/322700","article-title":"West Nile encephalitis: an emerging disease in the United States","volume":"33","author":"Marfin","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.7326\/0003-4819-141-5-200409070-00010","article-title":"Clinical characteristics and functional outcomes of West Nile fever","volume":"141","author":"Watson","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0020","unstructured":"Centers for disease control. West Nile Virus: Prevention Information and Guidance for Clinicians. Available at: http:\/\/www.cdc.gov\/ncidod\/dvbid\/westnile\/clinicians\/pdf\/wnv-prevention-clinguidance.pdf. [Accessed 14.011.11]."},{"issue":"24","key":"10.1016\/j.vaccine.2012.08.063_bib0025","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM200106143442401","article-title":"The outbreak of West Nile virus infection in the New York City area in 1999","volume":"344","author":"Nash","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0030","unstructured":"CDC. West Nile virus activity \u2013 United States, 2009. MMWR 2010;59:769\u201372."},{"key":"10.1016\/j.vaccine.2012.08.063_bib0035","unstructured":"CDC. West Nile virus disease and other arboviral diseases \u2013 United States, 2010. MMWR 2010;60(30):1009\u201313."},{"key":"10.1016\/j.vaccine.2012.08.063_bib0040","unstructured":"CDC. West Nile virus statistics, surveillance, and control. Available at: http:\/\/www.cdc.gov\/ncidod\/dvbid\/westnile\/surv&controlCaseCount12_detailed.htm. [Accessed: 09.08.12]."},{"issue":"2","key":"10.1016\/j.vaccine.2012.08.063_bib0045","first-page":"139","article-title":"West Nile virus: is a vaccine needed?","volume":"11","author":"Byron","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2012.08.063_bib0050","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2174\/1568005013343254","article-title":"West Nile virus vaccine","volume":"1","author":"Monath","year":"2001","journal-title":"Curr Drug Targets Infect Disord"},{"issue":"12","key":"10.1016\/j.vaccine.2012.08.063_bib0055","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3201\/eid0812.020229","article-title":"Efficacy of killed virus vaccine, live attenuated chimeric virus vaccine, and passive immunization for prevention of West Nile virus encephalitis in hamster model","volume":"8","author":"Tesh","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2012.08.063_bib0060","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"Arroyo","year":"2004","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2012.08.063_bib0065","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"Monath","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.063_bib0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/infdis\/jiq003","article-title":"Phase II randomized, double-blind, placebo-controlled, multi-center study to investigate the immunogenicity and safety of a West Nile Vaccine in healthy adults","volume":"203","author":"Biedenbender","year":"2011","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2012.08.063_bib0075","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/00031305.1997.10473947","article-title":"A look at the rule of three","volume":"51","author":"Jovanovic","year":"1997","journal-title":"Am Stat"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0080","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev Biol"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2012.08.063_bib0085","first-page":"221","article-title":"Recombinant canarypoxvirus vaccine carrying the prM\/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge","volume":"18","author":"Minke","year":"2004","journal-title":"Arch Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2012.08.063_bib0090","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1128\/JVI.75.9.4040-4047.2001","article-title":"West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays","volume":"75","author":"Davis","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0095","doi-asserted-by":"crossref","first-page":"7939","DOI":"10.1016\/j.vaccine.2010.09.076","article-title":"Development and evaluation of a formalin-inactivated West Nile virus vaccine (WN-VAX) for a human vaccine candidate","volume":"28","author":"Posadas-Herrera","year":"2010","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2012.08.063_bib0100","doi-asserted-by":"crossref","first-page":"8338","DOI":"10.1016\/j.vaccine.2007.09.055","article-title":"Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine","volume":"25","author":"Samina","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.063_bib0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.virol.2007.12.021","article-title":"Vero cell-derived inactivated West Nile (WN) vaccine induces protective immunity against lethal WN virus infection in mice and shows a facilitated neutralizing antibody response in mice previously immunized with Japanese encephalitis vaccine","volume":"374","author":"Lim","year":"2008","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.063_bib0110","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2004.09.014","article-title":"An attenuated West Nile prototype virus is highly immunogenic and protects against the deadly NY99 strain: a candidate for live WN vaccine development","volume":"330","author":"Yamshchikov","year":"2004","journal-title":"Virology"},{"issue":"47","key":"10.1016\/j.vaccine.2012.08.063_bib0115","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.1016\/j.vaccine.2008.08.064","article-title":"Attenuated West Nile viruses bearing 3\u2032SL and envelope gene substitution mutations","volume":"26","author":"Yu","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.063_bib0120","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.vaccine.2006.08.018","article-title":"Preparation and immunogenic properties of a recombinant West Nile subunit vaccine","volume":"25","author":"Lieberman","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2012.08.063_bib0125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.vaccine.2008.10.046","article-title":"A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+cells","volume":"27","author":"Bonafe","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2012.08.063_bib0130","doi-asserted-by":"crossref","first-page":"955","DOI":"10.4269\/ajtmh.2008.79.955","article-title":"Evaluation of the efficacy of a recombinant subunit West Nile vaccine in Syrian golden hamsters","volume":"79","author":"Sirin","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.063_bib0135","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/jgm.837","article-title":"A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus","volume":"8","author":"Iglesias","year":"2006","journal-title":"J Gene Med"},{"issue":"12","key":"10.1016\/j.vaccine.2012.08.063_bib0140","doi-asserted-by":"crossref","first-page":"e3973","DOI":"10.1371\/journal.pone.0003973","article-title":"Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine","volume":"3","author":"Coutant","year":"2008","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.063_bib0145","doi-asserted-by":"crossref","first-page":"e18995","DOI":"10.1371\/journal.pone.0018995","article-title":"A recombinant influenza A virus expressing domain III of West Nile virus induces protective immune responses against influenza and West Nile virus","volume":"6","author":"Martina","year":"2011","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2012.08.063_bib0150","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/523650","article-title":"A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial","volume":"196","author":"Martin","year":"2007","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2012.08.063_bib0155","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/infdis\/jir054","article-title":"A West Nile virus DNA vaccine utilizing a modified promoter induces neutralizing antibody in younger and older healthy adults in a phase I clinical trial","volume":"203","author":"Ledgerwood","year":"2011","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.063_bib0160","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biotechadv.2009.02.003","article-title":"Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production","volume":"27","author":"Williams","year":"2009","journal-title":"Biotechnol Adv"},{"issue":"1","key":"10.1016\/j.vaccine.2012.08.063_bib0165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0042-6822(03)00450-1","article-title":"Molecularly engineered live-attenuated chimeric West Nile\/dengue virus vaccines protect rhesus monkeys from West Nile virus","volume":"314","author":"Pletnev","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0170","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1586\/14760584.7.4.467","article-title":"Age-related decline in immunity: implications for vaccine responsiveness","volume":"7","author":"Kumar","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0175","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4269\/ajtmh.2004.71.639","article-title":"Construction of yellow fever\/St Louis encephalitis chimeric virus and the use of chimeras as a diagnostic tool","volume":"71","author":"Pugachev","year":"2004","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0180","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/CVI.00095-09","article-title":"Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests","volume":"16","author":"Johnson","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0185","series-title":"Vaccines","first-page":"959","article-title":"Yellow fever","author":"Monath","year":"2008"},{"issue":"45","key":"10.1016\/j.vaccine.2012.08.063_bib0190","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0195","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/infdis\/jiq074","article-title":"Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination","volume":"203","author":"Smith","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0200","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector memory CD8+ T cell responses to small pox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.vaccine.2012.08.063_bib0205","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"Monath","year":"2003","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.063_bib0210","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1086\/649916","article-title":"A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults","volume":"201","author":"Morrison","year":"2010","journal-title":"J Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2012.08.063_bib0215","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.vaccine.2011.03.057","article-title":"Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines","volume":"29","author":"Capeding","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.08.063_bib0220","first-page":"e9","article-title":"Live-attenuated tetravalent dengue vaccine in dengue-na\u00efve children, adolescents and adults in Mexico city: randomized controlled phase 1 trial of safety and immunogenicity","author":"Poo","year":"2010","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2012.08.063_bib0225","doi-asserted-by":"crossref","first-page":"724","DOI":"10.4269\/ajtmh.2011.10-0436","article-title":"Priming effect of dengue and yellow fever vaccination on the immunogenicity, infectivity, and safety of a tetravalent dengue vaccine in humans","volume":"85","author":"Qiao","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.063_bib0230","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/517806","article-title":"In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination","volume":"177","author":"Hacker","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2012.08.063_bib0235","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2249.2001.01621.x","article-title":"Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination","volume":"125","author":"Hacker","year":"2001","journal-title":"Clin Exp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12012819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12012819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:46:58Z","timestamp":1714351618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12012819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":47,"journal-issue":{"issue":"47","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0264410X12012819"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.08.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}